Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Study of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment
An upcoming clinical trial evaluating three endpoints to assess the benefit of rehabilitation in patients with advanced non-small cell lung …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer [NA]
A clinical trial comparing sublobar wedge resection versus stereotactic radiotherapy for high-risk patients with early-stage non-small cell …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6 [Phase 1]
Phase 1 clinical trial using a molecularly targeted radionuclide therapy directed at integrin alphavbeta6 for metastatic non-small cell lung…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1) [Phase 1]
A Phase 1 study (HEROEX-1) of NVL-330 in patients with advanced or metastatic HER2-altered non-small cell lung cancer is currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [NA]
This clinical trial update outlines a study of image-guided hypofractionated radiation therapy with a stereotactic body radiation therapy bo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial evaluating a PD-1 inhibitor with chemotherapy and concurrent irradiation for advanced non-small cell lung cancer; t…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis [Phase 2]
Phase 2 trial update for repotrectinib in ROS1-positive non-small cell lung cancer patients with active brain metastases; currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of TAK-788 in adults with non-small cell lung cancer, currently active but not recrui…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the combination of cemiplimab and fianlimab before surgery for stage IB-IIIB non-small cell lung cancer, currently …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the safety and tolerability of TransCon IL-2 β/γ alone or in combination w…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 [Phase 3]
A Phase 3 clinical trial evaluating Ivonescimab as first-line therapy for metastatic Non-Small Cell Lung Cancer in patients with high PD-L1 …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer [Phase 3]
An update on a Phase 3 trial evaluating self-management survivorship care for stage I-III non-small cell lung cancer and colorectal cancer.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
This Phase 2 trial aims to evaluate adverse events and pharmacokinetics of Telisotuzumab Vedotin as a standalone therapy in adults with prev…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns
This clinical trial update profiles demographics and clinical characteristics of non-small cell lung cancer patients and analyzes guideline-…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies [Phase 1]
A first-in-human Phase 1 study of PRTH-101 alone or with pembrolizumab in patients with advanced malignancies is recruiting, including non-s…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating trastuzumab deruxtecan for non-small cell lung cancer is currently recruiting, including stage II, IIIA,…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC [Phase 2]
This clinical trial update describes a Phase 2 study evaluating immunotherapy as consolidation therapy after radical treatment for synchrono…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment [Phase 2]
A Phase 2 trial evaluating the combination of lazertinib and tepotinib for EGFR-mutant metastatic non-small cell lung cancer with MET overex…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer [NA]
A clinical trial evaluating pre-operative tumor treating fields in patients with resectable non-small cell lung cancer; the study is not yet…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of a mesothelin-targeting logic-gated CAR T therapy in adults with solid tumors …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial [Phase 1]
Phase 1 clinical trial evaluating Izalontamab Brengitecan in combination with Adagrasib for non-small cell lung cancer; the study is current…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents [Phase 1, Phase 2]
Clinical trial update on ascending doses of ceralasertib in combination with chemotherapy or other anti-cancer agents in advanced solid mali…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
This clinical trial update describes a study evaluating early rebiopsy to identify biomarkers of tumor cell survival after EGFR, ALK, ROS1, …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy [Phase 1]
Phase 1 study of ITC-6146RO in patients with advanced or metastatic cancers after standard therapy; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Onco-primary Care Networking to Support TEAM-based Care [NA]
Clinical trial update noting that the Duke University study on oncology-primary care networking to support TEAM-based care is currently ACTI…